IL22 and inflammatory bowel disease: Research highlighting the regulation of interleukin-22 (IL-22) by AhR is of particular relevance to IBD as this cytokine impacts intestinal epithelial cell regeneration processes and is implicated in maintaining gut microbiome homeostasis (32, 35–39).